Drug Shortage Report for TEVA-OXYCOCET
Report ID | 110661 |
Drug Identification Number | 00608165 |
Brand name | TEVA-OXYCOCET |
Common or Proper name | OXYCOCET TABS 5MG/325MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
Strength(s) | 325MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02AJ |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-01 |
Estimated end date | 2020-07-31 |
Actual end date | 2020-07-22 |
Shortage status | Resolved |
Updated date | 2020-07-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-07-23 | French | Compare |
v7 | 2020-07-23 | English | Compare |
v6 | 2020-06-25 | French | Compare |
v5 | 2020-06-25 | English | Compare |
v4 | 2020-05-21 | French | Compare |
v3 | 2020-05-21 | English | Compare |
v2 | 2020-04-02 | French | Compare |
v1 | 2020-04-02 | English | Compare |
Showing 1 to 8 of 8